logo-loader
viewCanntab Therapeutics Ltd

Canntab Therapeutics building cannabis delivery facility with FSD Pharma

Canntab Therapeutics Ltd (CSE:PILL) CEO Jeff Renwick and CFO Richard Goldstein tell Proactive Investor's Christine Corrado the cannabis delivery manufacturing company is lining up its ducks ahead of the legalization of cannabis in Canada on October 17 this year - as it announced a profit sharing collaboration with medical pot producer FSD Pharma Inc.

Canntab will build, at its own expense, its own manufacturing facility to produce cannabis oral dose delivery platforms.

Quick facts: Canntab Therapeutics Ltd

Price: 0.36 CAD

CSE:PILL
Market: CSE
Market Cap: $9.11 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Canntab Therapeutics Ltd named herein, including the promotion by the Company of Canntab Therapeutics Ltd in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

2 min read